| Literature DB >> 33487626 |
Tsukumi Tondokoro1, Akinori Nakata1, Yasumasa Otsuka2, Nobuyuki Yanagihara3, Ayumi Anan4, Hiromi Kodama4, Noriaki Satoh5.
Abstract
Although participatory workplace improvement programs are known to provide favorable effects on high stress occupations like nursing, no studies have confirmed its effect using biomarkers. The aim of this study was to determine whether a participatory workplace improvement program would decrease stress-related symptoms as evaluated by biomarkers and self-reported stress among hospital nurses. Three actions to alleviate job stress, which were determined through focus group interviews and voting, were undertaken for two months. A total of 31 female Japanese nurses underwent measurement of inflammatory markers, autonomic nervous activity (ANA), and perceived job stress (PJS) at three-time points; before the program (T1), within a week after the completion of the program (T2), and three months after the program (T3). A series of inflammatory markers (Interferon-γ, Interleukin (IL)-6, and IL-12/23p40) decreased significantly at T2, and IL-12/23p40 and IL-15 significantly decreased at T3 compared to T1, while ANA and PJS remained unchanged. Our participatory program exerted beneficial effects in reducing inflammatory responses, but not for ANA and PJS. Further investigations with a better study design, i.e., a randomized controlled trial, and a larger sample size are warranted to determine what exerted beneficial effects on inflammatory markers and why other outcomes remained unchanged.Entities:
Keywords: Autonomic nervous activity; Focus group interview; Inflammatory markers; Job stress; Nurses; Participatory workplace improvement program; Voting
Year: 2021 PMID: 33487626 PMCID: PMC8010166 DOI: 10.2486/indhealth.2020-0176
Source DB: PubMed Journal: Ind Health ISSN: 0019-8366 Impact factor: 2.179
Fig. 1.Examples of obtained ideas from the focus group interviews. A group of interviewees raised ideas about on-duty, off-duty, and interpersonal issues.
Fig. 2.Flow chart of methods and study participants.
Baseline characteristics of female nurse participants (N=31)
| n | % | Median | Interquartile range | |
|---|---|---|---|---|
| Age | 38.0 | 25.0–42.0 | ||
| Marriage status | ||||
| Single | 22 | 71.0 | ||
| Married | 8 | 25.8 | ||
| Divorced | 1 | 3.2 | ||
| Number of years employed as a nurse | 7.0 | 3.0–20.0 | ||
| Number of participants by units and departments | ||||
| A (orthopaedics, gastrointestinal surgery, obstetrics and gynecology unit) | 5 | 16.1 | ||
| B (rheumatology, diabetic tract medicine, pulmonary medicine, cardiovascular medicine, and nephrology unit) | 4 | 12.9 | ||
| C (gastrointestinal medicine, palliative care, hematology, oncology, and urology unit) | 6 | 19.3 | ||
| D (operation department) | 5 | 16.1 | ||
| E (out-patient department) | 5 | 16.1 | ||
| F (home nursing department) | 5 | 16.1 | ||
| G (nursing department) | 1 | 3.2 | ||
| Work shift | ||||
| Daytime | 19 | 61.3 | ||
| 2-Shifts | 12 | 38.7 | ||
| Overtime (hours/last month) | 9.25 | 4.60–16.50 | ||
| Average sleep hours on work days | 6.00 | 6.00–7.00 | ||
| < 6 h | 3 | 9.7 | ||
| ≥ 6 h | 28 | 90.3 | ||
| Menstrual cycle | ||||
| Menstruation | 3 | 9.7 | ||
| Follicular phase | 7 | 22.6 | ||
| Luteal phase | 14 | 45.2 | ||
| Menopause | 4 | 12.9 | ||
| Other | 1 | 3.2 | ||
| Not ascertained | 2 | 6.5 |
Differences in inflammatory markers at T1, T2, and T3
| T1 | T2 | T3 | ||||||||||||
| Median | Interquartile range | Mean | SD | Median | Interquartile range | Mean | SD | Median | Interquartile range | Mean | SD | |||
| IFN-γ (pg/ml)a | 2.76 | (2.05–4.91) | 2.15 | (1.31–3.48) | 2.68 | (1.86–3.92) | 0.004 | T1 vs. T2: 0.003, | ||||||
| T1 vs. T3: 0.432, | ||||||||||||||
| T2 vs. T3: 0.197 | ||||||||||||||
| IL-6 (pg/ml)a | 0.46 | (0.24–0.60) | 0.35 | (0.25–0.54) | 0.36 | (0.29–0.56) | 0.044 | T1 vs. T2: 0.047, | ||||||
| T1 vs. T3: 0.226, | ||||||||||||||
| T2 vs. T3: 1.000 | ||||||||||||||
| TNF-α (pg/ml)a | 1.46 | (1.25–1.82) | 1.42 | (1.10–1.68) | 1.33 | (1.20–1.62) | 0.244 | |||||||
| IL-12/23p40 (pg/ml)a | 124 | (98.7–154.0) | 102 | (83.4–127.0) | 115 | (87.1–137.0) | 0.003 | T1 vs. T2: 0.004, | ||||||
| T1 vs. T3: 0.019, | ||||||||||||||
| T2 vs. T3: 1.000 | ||||||||||||||
| IL-15 (pg/ml)b | 2.76 | 0.44 | 2.75 | 0.48 | 2.6 | 0.42 | 0.009 | T1 vs. T2: 1.000, | ||||||
| T1 vs. T3: 0.015, | ||||||||||||||
| T2 vs. T3: 0.058 | ||||||||||||||
| IL-27 (pg/ml)a | 1050 | (935–1300) | 973 | (886–1220) | 1090 | (887–1400) | 0.089 | |||||||
| hs-CRP (mg/dl)a | 0.013 | (0.007–0.032) | 0.013 | (0.006–0.031) | 0.013 | (0.008–0.042) | 0.304 | |||||||
aFriedman’s test.
bOne-way analysis of variance.
cBonferroni test.
The values with the non-Gaussian distribution are shown as medians and interquartile range. The values with the Gaussian distribution are shown as means and SDs.
T1: baseline (before the program); T2: immediately after the program; T3: 3 months after the program; IFN: interferon; IL: interleukin; TNF: tumor necrosis factor; hs-CRP: high-sensitivity C-reactive protein.
Table 3. Differences in autonomic nervous activity at T1, T2, and T3
| T1 | T2 | T3 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | Interquartile range | Mean | SD | Median | Interquartile range | Mean | SD | Median | Interquartile range | Mean | SD | ||
| Low frequency/total frequency (standing)a | 0.71 | (0.62–0.76) | 0.75 | (0.65–0.81) | 0.76 | (0.63–0.83) | 0.368 | ||||||
| Mean R-R interval/ R-R interval per minutes (standing)a | 223.4 | (172.7–273.0) | 236.4 | (179.4–261.6) | 225.9 | (180.2–263.0) | 0.542 | ||||||
| Mean R-R interval (supine-standing)a | 157.6 | (96.7–204.4) | 147.8 | (123.5–196.9) | 142.2 | (113.0–193.0) | 0.542 | ||||||
| Mean R-R interval (supine)b | 841.3 | 112.3 | 839.9 | 112.0 | 836.7 | 106.0 | 0.969 | ||||||
| High frequency/total frequency (supine)a | 0.62 | (0.53–0.71) | 0.65 | (0.50–0.77) | 0.68 | (0.54–0.74) | 0.798 | ||||||
| SDRR (supine)a | 29.2 | (23.7–41.7) | 32.7 | (24.8–40.5) | 32.8 | (24.7–42.6) | 0.968 | ||||||
| Sympathetic nerve/parasympathetic nerve ratiob | 1.02 | 0.26 | 1.08 | 0.28 | 1.05 | 0.25 | 0.286 | ||||||
aFriedman’s test.
bOne-way analysis of variance.
The values with the non-Gaussian distribution are shown as medians and interquartile range. The values with the Gaussian distribution are shown as means and SDs.
T1: baseline (before the program); T2: immediately after the program; T3: 3 months after the program; SDRR: standard deviation of R-R intervals.
Differences in evaluation of perceived job stress, job satisfaction, and depressive symptoms at T1, T2, and T3
| Number of items | T1 | T2 | T3 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Median | Interquartilerange | Mean | SD | α | Median | Interquartilerange | Mean | SD | α | Median | Interquartilerange | Mean | SD | α | ||||
| Psychosocial job stress | ||||||||||||||||||
| Quantitative workloadb, c | 3 | 8.7 | 1.6 | 0.73 | 8.9 | 1.6 | 0.68 | 8.8 | 1.9 | 0.61 | 0.618 | |||||||
| Qualitative workloada, c | 3 | 9 | (9.0–10.0) | 0.56 | 9 | (8.0–10.0) | 0.80 | 9 | (9.0–10.0) | 0.72 | 0.611 | |||||||
| Job controla | 3 | 7 | (6.0–9.0) | 0.61 | 7 | (6.0–8.0) | 0.72 | 7 | (6.0–8.0) | 0.67 | 0.946 | |||||||
| Interpersonal conflicta, c | 3 | 6 | (6.0–9.0) | 0.36 | 6 | (5.0–7.0) | 0.61 | 6 | (6.0–7.0) | 0.68 | 0.542 | |||||||
| Psychological and physical stress reactions | ||||||||||||||||||
| Vigora | 3 | 6 | (3.0–6.0) | 0.93 | 5 | (3.0–6.0) | 0.91 | 5 | (3.0–6.0) | 0.87 | 0.327 | |||||||
| Irritationa, c | 3 | 6 | (5.0–8.0) | 0.89 | 5 | (4.0–7.3) | 0.85 | 5 | (4.0–6.0) | 0.80 | 0.291 | |||||||
| Fatiguea, c | 3 | 7 | (6.0–9.0) | 0.90 | 7 | (5.0–9.0) | 0.92 | 6 | (5.0–9.0) | 0.93 | 0.192 | |||||||
| Anxietya, c | 3 | 5 | (4.0–7.0) | 0.79 | 5 | (3.0–7.0) | 0.82 | 4 | (3.0–6.0) | 0.24 | 0.209 | |||||||
| Physical stress responseb, c | 11 | 18.9 | 4.9 | 0.79 | 19 | 5.1 | 0.80 | 17.3 | 4.6 | 0.80 | 0.048 | T1 vs. T2: 1.000, | ||||||
| T1 vs. T3: 0.262, | ||||||||||||||||||
| T2 vs. T3: 0.071 | ||||||||||||||||||
| Job satisfactiona | 4 | 9 | (8.0–10.0) | 0.68 | 9 | (8.0–10.0) | 0.67 | 9 | (8.0–9.0) | 0.79 | 0.841 | |||||||
| CES-Da, c | 20 | 14 | (10.0–18.5) | 0.77 | 12.5 | (8.0–19.0) | 0.9 | 12 | (7.0–16.0) | 0.86 | 0.077 | |||||||
aFriedman’s test.
bOne-way analysis of variance.
cNegatively oriented.
dBonferroni test.
The values with the non-Gaussian distribution are shown as medians and interquartile range. The values with the Gaussian distribution are shown as means and SDs.
T1: baseline (before the program); T2: immediately after the program; T3: 3 months after the program; CES-D: Center for Epidemiologic Studies Depression Scale.